Wellgistics Health, Inc.
WGRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $18 | $0 | $33 |
| % Growth | – | -100% | – |
| Cost of Goods Sold | $16 | $0 | $27 |
| Gross Profit | $2 | $0 | $6 |
| % Margin | 9.7% | – | 17.5% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $7 | $3 | $7 |
| SG&A Expenses | $7 | $3 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $1 | -$0 | $2 |
| Operating Expenses | $8 | $3 | $9 |
| Operating Income | -$6 | -$3 | -$3 |
| % Margin | -33.9% | – | -10.4% |
| Other Income/Exp. Net | -$1 | -$0 | $1 |
| Pre-Tax Income | -$7 | -$3 | -$3 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$7 | -$3 | -$3 |
| % Margin | -37.8% | – | -8.4% |
| EPS | -0.13 | -0.06 | -0.058 |
| % Growth | -116.7% | -3.3% | – |
| EPS Diluted | -0.13 | -0.06 | -0.058 |
| Weighted Avg Shares Out | 52 | 45 | 47 |
| Weighted Avg Shares Out Dil | 52 | 45 | 47 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $2 |
| EBITDA | -$5 | -$3 | -$0 |
| % Margin | -27.1% | – | -1.1% |